EUVIMEDEUVIMED entdecken
Multizentrische Studie

Clinical and Angiographic Outcomes of a Novel Thin Strut Poly(L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study

Marianne Brodmann, Batla Falah, Luis Mariano Palena, Kong Teng Tan, Flavio Airoldi, Francesco Liistro, Mahmood K Razavi, Sahil A Parikh, Eric A Secemsky, Juan F Granada

European Journal of Vascular and Endovascular Surgery · 2025

DOI: 10.1016/j.ejvs.2025.07.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Vascular and Endovascular Surgery, 2025. Verfasst von Marianne Brodmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Angiology, Medical University Graz, Graz, Austria. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Absorbable Implants, Polyesters, Sirolimus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This first in human study evaluated the six month angiographic and one year clinical outcomes of a novel thin strut, sirolimus eluting, resorbable scaffold for symptomatic below knee peripheral arterial disease (PAD). RESOLV I is an international, prospective, multicentre, single arm study assessing the performance of the MAGNITUDE drug eluting resorbable scaffold (DRS) for the treatment of below knee lesions in patients with symptomatic PAD. METHODS: Angiographic and duplex ultrasound evaluations were performed by independent core labs at baseline, post-DRS implantation, and at six months follow up. Binary re-stenosis (> 50% diameter stenosis) was determined via quantitative vascular angiography or duplex ultrasound when quantitative vascular angiography was unavailable. Peri-operative death, major adverse limb events, and functional status were evaluated up to one year. RESULTS: Thirty five patients (mean age 74.5 ± 6.0 years) were enrolled: six (17%) had chronic total occlusion lesions and 25 (71%) had a baseline Rutherford-Becker classification of stage 5. The mean lesion length was 30.1 ± 12.0 mm. The binary re-stenosis rate at 6 months was 10% (3/31) (angiographic patency of 90%) and mean in segment late lumen loss was 0.75 ± 0.74 mm. Improved Rutherford class at 12 months follow up was achieved in 88% (29/33) of patients and most were asymptomatic (Rutherford-Becker class 0). No amputation or clinically driven target lesion revascularisation events were seen through 12 months. CONCLUSION: Early results of the RESOLV I study showed that implantation of a thin strut MAGNITUDE DRS achieved low binary re-stenosis rates at six months, as well as improvement in functional status, with no clinically driven target lesion revascularisation at one year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseAbsorbable ImplantsPolyestersSirolimusCardiovascular AgentsEndovascular ProceduresHumansAgedMaleFemaleProspective StudiesTreatment OutcomeProsthesis DesignAged, 80 and overUltrasonography, Doppler, DuplexMiddle AgedAngiographyTime FactorsVascular Patency

Stichwörter der Autor:innen

AngiographyBioresorbable scaffoldRESOLV ISymptomatic below knee peripheral arterial disease

Substanzen

PolyestersSirolimuspoly(lactide)Cardiovascular Agents

Autor:innen und Institutionen

  • Division of Angiology, Medical University Graz, Graz, Austria.
  • Clinical Trials Centre, Cardiovascular Research Foundation, New York, NY, USA.
  • Interventional Radiology Unit, Policlinico Abano Terme, Abano Terme, Italy.
  • Division of Interventional Radiology, Toronto General Hospital, Toronto, ON, Canada.
  • Interventional Cardiology Unit, IRCCS MultiMedica, Milan, Italy.
  • San Donato Hospital, Arezzo, Health Authorities Southeast Tuscany, Arezzo, Italy.

Zitieren

APA

Brodmann, M., Falah, B., Palena, L. M., Tan, K. T., Airoldi, F., Liistro, F., Razavi, M. K., Parikh, S. A., Secemsky, E. A., & Granada, J. F. (2025). Clinical and Angiographic Outcomes of a Novel Thin Strut Poly(L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study. European Journal of Vascular and Endovascular Surgery. https://doi.org/10.1016/j.ejvs.2025.07.017

Vancouver

Brodmann M, Falah B, Palena LM, Tan KT, Airoldi F, Liistro F, et al. Clinical and Angiographic Outcomes of a Novel Thin Strut Poly(L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study. European Journal of Vascular and Endovascular Surgery. 2025. doi:10.1016/j.ejvs.2025.07.017

BibTeX
@article{Brodmann2025,
  author = {Brodmann, Marianne and Falah, Batla and Palena, Luis Mariano and Tan, Kong Teng and Airoldi, Flavio and Liistro, Francesco and Razavi, Mahmood K and Parikh, Sahil A and Secemsky, Eric A and Granada, Juan F},
  title = {Clinical and Angiographic Outcomes of a Novel Thin Strut Poly(L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study},
  journal = {European Journal of Vascular and Endovascular Surgery},
  year = {2025},
  doi = {10.1016/j.ejvs.2025.07.017}
}
Kostenlos starten →